Literature DB >> 29710320

Value-Based Pricing for Drugs: Theme and Variations.

Anna Kaltenboeck1, Peter B Bach1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29710320     DOI： 10.1001/jama.2018.4871

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

1.  Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis.

Authors:  Marcus S Shaker; Matthew J Greenhawt
Journal:  JAMA Pediatr       Date:  2019-02-01       Impact factor: 16.193

Review 2.  Impact of exercise on the immune system and outcomes in hematologic malignancies.

Authors:  Andrea Sitlinger; Danielle M Brander; David B Bartlett
Journal:  Blood Adv       Date:  2020-04-28

Review 3.  Review of Current Policy Strategies to Reduce US Cancer Drug Costs.

Authors:  Angela K Green; Jennifer A Ohn; Peter B Bach
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

4.  Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States.

Authors:  Eric L Ross; Djøra I Soeteman
Journal:  Psychiatr Serv       Date:  2020-07-07       Impact factor: 3.084

5.  Priceless Knowledge: Attitudes and Awareness Around Drug Pricing Among US Medical Students.

Authors:  Deborah Korenstein; Anna Kaltenboeck; Maha Mamoor; Susan Chimonas
Journal:  Med Sci Educ       Date:  2021-01-13

6.  Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China.

Authors:  Yichen Zhang; Yuxuan Wei; Huangqianyu Li; Yixuan Chen; Yiran Guo; Sheng Han; Luwen Shi; Xiaodong Guan
Journal:  Pharmacoeconomics       Date:  2022-06-29       Impact factor: 4.558

7.  A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals.

Authors:  Paul Sorum; Christopher Stein; Danielle Wales; David Pratt
Journal:  Int J Health Serv       Date:  2022-05-12       Impact factor: 1.851

8.  Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.

Authors:  Julia Spoendlin; Julie M Paik; T Tsacogianis; Seoyoung C Kim; Sebastian Schneeweiss; Rishi J Desai
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

9.  Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors:  Eric D Shah; Sameer D Saini; William D Chey
Journal:  Clin Gastroenterol Hepatol       Date:  2019-03-01       Impact factor: 11.382

Review 10.  Immuno-Oncology Medicines: Policy Implications and Economic Considerations.

Authors:  Georges Adunlin; Stefanie P Ferreri; Jenny Dong; Maisha Kelly Freeman
Journal:  Innov Pharm       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.